Evidence map›Paper›PMID 23985870›Full record

ArticleNature2013

Richness of human gut microbiome correlates with metabolic markers.

Emmanuelle Le Chatelier, Trine Nielsen, Junjie Qin, Edi Prifti, Falk Hildebrand, Gwen Falony, Mathieu Almeida, Manimozhiyan Arumugam, Jean-Michel Batto, Sean Kennedy and 32 more

7 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 2,458 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,458citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03396198 unknown statusnot on this mapstarted 2017, after this paper: background citation

An Observational Study of Intestinal Flora in Infants

TypeobservationalSponsorMizu JiangRan2017 to 2020Enrolled100ConditionsGastrointestinal Microbiome
NCT03483246 phase3active not recruitingnot on this mapstarted 2018, after this paper: background citation

Impact of Fecal Microbiota Transplantation in Ulcerative Colitis: a Randomized, Sham Controlled Trial

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2018 to 2027Enrolled150ConditionsUlcerative ColitisArmsFecal Microbiota Transplantation (FMT), Sham-transplantation Placebo
NCT03627104 nacompletednot on this mapstarted 2018, after this paper: background citation

Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2018 to 2020Enrolled80ConditionsObesity, Insulin ResistanceArmsNormoprotein diet with animal protein, Normoprotein diet with vegetable protein, High-protein diet with animal protein, High-protein diet with vegetable protein
NCT03723486 unknown statusnot on this mapstarted 2015, after this paper: background citation

Changes in the Intestinal and Oral Microbiome of Morbidly Obese Patients Undergoing Gastric Bypass Surgery in Relation to Insulin Resistance and Metabolic Syndrome

TypeobservationalSponsorUniversity Health Network, TorontoRan2015 to 2023Enrolled120ConditionsObesity
NCT03728868 nacompletednot on this mapstarted 2018, after this paper: background citation

Tolerability and Risk of Adverse Events With a Probiotic Supplement: A Randomised and Placebo Controlled Study in Healthy Individuals

TypeinterventionalSponsorSahlgrenska University HospitalRan2018 to 2019Enrolled50ConditionsHealthy IndividualsArmsPlacebo, High dose F. prausnitzii and D. piger, Low dose F. prausnitzii and D. piger
NCT04642482 phase4completednot on this mapstarted 2019, after this paper: background citation

The Effect of Synbiotic on Intestinal Microbiota and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) on Obesity

TypeinterventionalSponsorHasanuddin UniversityRan2019 to 2020Enrolled16ConditionsObesity, Insulin ResistanceArmsSynbiotic (Rillus), Placebo
NCT04997733 phase3recruitingnot on this mapstarted 2021, after this paper: background citation

Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2021 to 2029Enrolled150ConditionsCrohn DiseaseArmsFecal Microbiota Transplantation (FMT), Sham-transplantation (placebo)
3 · Its place in the literature

Who cites it

2,458 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Global Microbiome: Core and Unique Signatures Across Diverse Populations.International journal of molecular sciences · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Effect of pasteurizedGut microbes · 2026
    Trial
  8. Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Trial
  9. Trial
  10. Trial
  11. Microbiome-Modulating Effects of Heat-TreatedJournal of microbiology and biotechnology · 2026
    Trial
  12. Trial
  13. Effect ofNutrients · 2026
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

2,398 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

Emmanuelle Le ChatelierINRA, Institut National de la Recherche Agronomique, US1367 Metagenopolis, 78350 Jouy en Josas, France.
Trine Nielsen
Junjie Qin
Edi Prifti
Falk Hildebrand
Gwen Falony
Mathieu Almeida
Manimozhiyan Arumugam
Jean-Michel Batto
Sean Kennedy
Pierre Leonard
Junhua Li
Kristoffer Burgdorf
Niels Grarup
Torben Jørgensen
Ivan Brandslund
Henrik Bjørn Nielsen
Agnieszka S Juncker
Marcelo Bertalan
Florence Levenez
Nicolas Pons
Simon Rasmussen
Shinichi Sunagawa
Julien Tap
Sebastian Tims
Erwin G Zoetendal
Søren Brunak
Karine Clément
Joël Doré
Michiel Kleerebezem
Karsten Kristiansen
Pierre Renault
Thomas Sicheritz-Ponten
Willem M de Vos
Jean-Daniel Zucker
Jeroen Raes
Torben Hansen
MetaHIT consortium
Peer Bork
Jun Wang
S Dusko Ehrlich
Oluf Pedersen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We are facing a global metabolic health crisis provoked by an obesity epidemic. Here we report the human gut microbial composition in a population sample of 123 non-obese and 169 obese Danish individuals. We find two groups of individuals that differ by the number of gut microbial genes and thus gut bacterial richness. They contain known and previously unknown bacterial species at different proportions; individuals with a low bacterial richness (23% of the population) are characterized by more marked overall adiposity, insulin resistance and dyslipidaemia and a more pronounced inflammatory phenotype when compared with high bacterial richness individuals. The obese individuals among the lower bacterial richness group also gain more weight over time. Only a few bacterial species are sufficient to distinguish between individuals with high and low bacterial richness, and even between lean and obese participants. Our classifications based on variation in the gut microbiome identify subsets of individuals in the general white adult population who may be at increased risk of progressing to adiposity-associated co-morbidities.

Indexed as

MetagenomeAdiposityAdultBacteriaBiomarkersBody Mass IndexCase-Control StudiesDietDyslipidemiasEnergy MetabolismEuropeFemaleGastrointestinal TractGenes, BacterialHumansInflammationBiomarkers

Identifiers

PMID23985870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.